| 13 févr. 2026 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 13 871 | 7.78 USD | |
| 14 janv. 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 50 000 | 0.00 USD | |
| 14 janv. 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 150 000 | 0.00 USD | deriv |
| 24 oct. 2025 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 18 660 | 17.01 USD | |
| 27 oct. 2025 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 8 973 | 17.14 USD | |
| 24 oct. 2025 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 18 660 | 4.26 USD | |
| 27 oct. 2025 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 8 973 | 4.26 USD | |
| 24 oct. 2025 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 18 660 | 0.00 USD | deriv |
| 27 oct. 2025 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 8 973 | 0.00 USD | deriv |
| 14 févr. 2025 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 7 134 | 8.76 USD | |
| 31 janv. 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 68 100 | 0.00 USD | |
| 31 janv. 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 228 800 | 0.00 USD | deriv |
| 17 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 1 770 | 4.26 USD | |
| 17 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 9 333 | 46.02 USD | |
| 18 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 11 667 | 30.00 USD | |
| 17 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 1 770 | 46.02 USD | |
| 17 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 9 333 | 30.00 USD | |
| 14 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 12 487 | 50.17 USD | |
| 14 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 12 487 | 4.26 USD | |
| 14 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 16 830 | 50.17 USD | |
| 14 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 16 830 | 14.10 USD | |
| 18 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 11 667 | 42.24 USD | |
| 18 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 2 322 | 42.24 USD | |
| 18 juin 2024 | EXERCISE | Corbus Pharmaceuticals Holdings, Inc. | 2 322 | 4.26 USD | |
| 18 juin 2024 | SALE | Corbus Pharmaceuticals Holdings, Inc. | 1 770 | 42.24 USD | |